Agilent introduces the altura line of inert hplc columns for superior results in biotherapeutic testing

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) today announced the release of a new range of high performance liquid chromatography (hplc) columns ideally suited for biotherapeutics applications. the agilent altura ultra inert hplc columns set a new standard in liquid chromatography performance, providing the reliability and efficiency biopharmaceutical companies need for the most demanding applications, including peptide glp-1 and oligonucleotide therapeutic developm.
A Ratings Summary
A Quant Ranking